Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 173

1.

Assessing the role of hypothalamic microglia and blood vessel disruption in the development of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats.

Korpal AK, Brown CH, Schwenke DO.

Pflugers Arch. 2018 Jun;470(6):883-895. doi: 10.1007/s00424-018-2128-x. Epub 2018 Mar 2.

PMID:
29500668
2.

Construction of a coarse-grain quasi-classical trajectory method. I. Theory and application to N2-N2 system.

Macdonald RL, Jaffe RL, Schwenke DW, Panesi M.

J Chem Phys. 2018 Feb 7;148(5):054309. doi: 10.1063/1.5011331.

PMID:
29421898
3.

Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.

Neale JPH, Pearson JT, Katare R, Schwenke DO.

Front Endocrinol (Lausanne). 2017 Dec 13;8:350. doi: 10.3389/fendo.2017.00350. eCollection 2017. Review.

4.

Ghrelin Preserves Ischemia-Induced Vasodilation of Male Rat Coronary Vessels Following β-Adrenergic Receptor Blockade.

Pearson JT, Collie N, Lamberts RR, Inagaki T, Yoshimoto M, Umetani K, Davis P, Wilkins G, Jones PP, Shirai M, Schwenke DO.

Endocrinology. 2018 Apr 1;159(4):1763-1773. doi: 10.1210/en.2017-03070.

PMID:
29325034
5.

Widespread Coronary Dysfunction in the Absence of HDL Receptor SR-B1 in an Ischemic Cardiomyopathy Mouse Model.

Pearson JT, Yoshimoto M, Chen YC, Sultani R, Edgley AJ, Nakaoka H, Nishida M, Umetani K, Waddingham MT, Jin HL, Zhang Y, Kelly DJ, Schwenke DO, Inagaki T, Tsuchimochi H, Komuro I, Yamashita S, Shirai M.

Sci Rep. 2017 Dec 22;7(1):18108. doi: 10.1038/s41598-017-18485-6.

6.

A switch from GABA inhibition to excitation of vasopressin neurons exacerbates the development angiotensin II-dependent hypertension.

Korpal AK, Han SY, Schwenke DO, Brown CH.

J Neuroendocrinol. 2017 Dec 9. doi: 10.1111/jne.12564. [Epub ahead of print]

PMID:
29222949
7.

Optimizing dietary patterns to decrease premature mortality.

Schwenke DC.

Curr Opin Lipidol. 2017 Aug;28(4):381-382. doi: 10.1097/MOL.0000000000000437. No abstract available.

PMID:
28700379
8.

Let's decide together: Differences between individual and joint delay discounting.

Schwenke D, Dshemuchadse M, Vesper C, Bleichner MG, Scherbaum S.

PLoS One. 2017 Apr 20;12(4):e0176003. doi: 10.1371/journal.pone.0176003. eCollection 2017.

9.

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.

Saremi A, Howell S, Schwenke DC, Bahn G, Beisswenger PJ, Reaven PD; VADT Investigators.

Diabetes Care. 2017 Apr;40(4):591-598. doi: 10.2337/dc16-1875. Epub 2017 Feb 1.

10.

Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways.

Lew JK, Pearson JT, Schwenke DO, Katare R.

Cardiovasc Diabetol. 2017 Jan 13;16(1):10. doi: 10.1186/s12933-016-0484-4. Review.

11.

Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.

Espinoza SE, Wang CP, Tripathy D, Clement SC, Schwenke DC, Banerji MA, Bray GA, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Stentz FB, Reaven PD, DeFronzo RA, Musi N.

Age (Dordr). 2016 Dec;38(5-6):485-493. doi: 10.1007/s11357-016-9946-6. Epub 2016 Sep 1.

12.

Increasing dietary fruits and vegetables to reduce healthcare costs.

Schwenke DC.

Curr Opin Lipidol. 2016 Aug;27(4):422-3. doi: 10.1097/MOL.0000000000000323. No abstract available.

PMID:
27383282
13.

Chronic intermittent hypoxia accelerates coronary microcirculatory dysfunction in insulin-resistant Goto-Kakizaki rats.

Chen YC, Inagaki T, Fujii Y, Schwenke DO, Tsuchimochi H, Edgley AJ, Umetani K, Zhang Y, Kelly DJ, Yoshimoto M, Nagai H, Evans RG, Kuwahira I, Shirai M, Pearson JT.

Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1.

14.

Delayed coronary reperfusion is ineffective at impeding the dynamic increase in cardiac efferent sympathetic nerve activity following myocardial ischemia.

Hall TM, Gordon C, Roy R, Schwenke DO.

Basic Res Cardiol. 2016 May;111(3):35. doi: 10.1007/s00395-016-0556-3. Epub 2016 Apr 19.

PMID:
27093872
15.

Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study.

Dev S, Hoffman TK, Kavalieratos D, Heidenreich P, Wu WC, Schwenke DC, Tracy SJ.

J Am Heart Assoc. 2016 Mar 31;5(3):e002493. doi: 10.1161/JAHA.115.002493.

16.

Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the 'obesity paradox'.

Diong C, Jones PP, Tsuchimochi H, Gray EA, Hughes G, Inagaki T, Bussey CT, Fujii Y, Umetani K, Shirai M, Schwenke DO.

Int J Obes (Lond). 2016 Jun;40(6):938-46. doi: 10.1038/ijo.2016.33. Epub 2016 Feb 23.

PMID:
27001546
17.

Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW.

Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, DeFronzo RA.

J Clin Endocrinol Metab. 2016 May;101(5):2056-62. doi: 10.1210/jc.2015-4202. Epub 2016 Mar 16.

PMID:
26982008
18.

Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes.

Koska J, Yassine H, Trenchevska O, Sinari S, Schwenke DC, Yen FT, Billheimer D, Nelson RW, Nedelkov D, Reaven PD.

J Lipid Res. 2016 May;57(5):894-905. doi: 10.1194/jlr.P064816. Epub 2016 Mar 3.

19.

Ghrelin Promotes Functional Angiogenesis in a Mouse Model of Critical Limb Ischemia Through Activation of Proangiogenic MicroRNAs.

Katare R, Rawal S, Munasinghe PE, Tsuchimochi H, Inagaki T, Fujii Y, Dixit P, Umetani K, Kangawa K, Shirai M, Schwenke DO.

Endocrinology. 2016 Feb;157(2):432-45. doi: 10.1210/en.2015-1799. Epub 2015 Dec 16.

PMID:
26672806
20.

Induction of hypertension blunts baroreflex inhibition of vasopressin neurons in the rat.

Han SY, Bouwer GT, Seymour AJ, Korpal AK, Schwenke DO, Brown CH.

Eur J Neurosci. 2015 Nov;42(9):2690-8. doi: 10.1111/ejn.13062. Epub 2015 Oct 5.

PMID:
26342194

Supplemental Content

Loading ...
Support Center